Eve Lalancette
Overview
Explore the profile of Eve Lalancette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Charlebois-Poirier A, Davoudi S, Lalancette E, Knoth I, Lippe S
Sci Rep
. 2025 Jan;
15(1):1531.
PMID: 39789112
Quantifying cognitive potential relies on psychometric measures that do not directly reflect cortical activity. While the relationship between cognitive ability and resting state EEG signal dynamics has been extensively studied...
2.
Lalancette E, Cantin E, Routhier M, Mailloux C, Bertrand M, Kiaei D, et al.
J Neurooncol
. 2024 Mar;
167(3):447-454.
PMID: 38443693
Purpose: The use of trametinib in the treatment of pediatric low-grade gliomas (PLGG) and plexiform neurofibroma (PN) is being investigated in an ongoing multicenter phase II trial (NCT03363217). Preliminary data...
3.
Lalancette E, Charlebois-Poirier A, Agbogba K, Knoth I, Cote V, Perreault S, et al.
Brain Res
. 2023 Jul;
1818:148512.
PMID: 37499730
Children with neurofibromatosis type 1 (NF1) are at increased risk of developing cognitive problems, including attention deficits and learning difficulties. Alterations in brain response to repetition and change have been...
4.
Fauteux A, Gutierrez Rojas R, Agbogba K, Benovoy M, Charlebois-Poirier A, Lalancette E, et al.
Pediatr Int
. 2023 Jan;
65(1):e15482.
PMID: 36680389
Background: Acute Kawasaki disease (KD) induces central nervous system inflammation and excessive irritability. Long-term impacts on children's neurodevelopment have only been studied marginally. This pilot study aimed to describe the...
5.
Lalancette E, Charlebois-Poirier A, Agbogba K, Knoth I, Jones E, Mason L, et al.
J Neurodev Disord
. 2022 Jul;
14(1):42.
PMID: 35869419
Background: Neurofibromatosis type 1 (NF1) is a genetic disorder often associated with cognitive dysfunctions, including a high occurrence of deficits in visuoperceptual skills. The neural underpinnings of these visuoperceptual deficits...
6.
Sheppard E, Lalancette E, Thebault-Dagher F, Lafontaine M, Knoth I, Gravel J, et al.
Epileptic Disord
. 2021 Apr;
23(2):325-336.
PMID: 33814363
Objective: Our goal was to assess development, cognition and behaviour following an initial complex febrile seizure (FS), at onset and school age, in the context of known risk factors for...
7.
Cote V, Lalancette E, Knoth I, Cote L, Agbogba K, Vannasing P, et al.
Brain Res
. 2020 Nov;
1751:147205.
PMID: 33189692
Sensory processing is the gateway to information processing and more complex processes such as learning. Alterations in sensory processing is a common phenotype of many genetic syndromes associated with intellectual...